# Epigral (NSE: EPIGRAL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/EPIGRAL · Pivot · prices to 22 Oct 2026

Epigral (NSE: EPIGRAL) closed at ₹949.40 on 22 Oct 2026, up 1.46% on the day. With a market capitalisation of ₹4,096 Cr, it ranks 861st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Chemicals.

At its last close the stock traded at 12.3× trailing earnings, against a return on equity of 14.9% in FY26. Over the past year the share price has fallen 43.6%. Its 52-week range is ₹807.00 (30 Mar 2026) to ₹1,729.90 (29 Oct 2025); the last close is 45.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹146 Cr (+20.3% year on year) and net profit ₹2 Cr (+71.0%), on a consolidated basis. Promoters held 68.83% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹949.40 |
| Market cap | ₹4,096 Cr |
| P/E (trailing) | 12.3 |
| ROE | 14.9% (FY26) |
| ROCE | 14.8% (FY26) |
| Debt to equity | 0.25 |
| 52-week high | ₹1,729.90 (29 Oct 2025) |
| 52-week low | ₹807.00 (30 Mar 2026) |
| 1-year return | −43.6% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹146 Cr | +20.3% | ₹2 Cr | +71.0% | ₹1.98 |
| Q3 FY26 | ₹141 Cr | +52.3% | ₹3 Cr | +580.0% | ₹2.67 |
| Q2 FY26 | ₹138 Cr | +53.3% | ₹2 Cr | +48.8% | ₹2.11 |
| Q1 FY26 | ₹107 Cr | +88.6% | ₹2 Cr | +276.7% | ₹1.60 |
| Q4 FY25 | ₹121 Cr | +93.8% | ₹1 Cr | +54.1% | ₹1.16 |
| Q3 FY25 | ₹93 Cr | +27.7% | ₹0 Cr | −66.9% | ₹0.40 |
| Q2 FY25 | ₹90 Cr | +30.7% | ₹2 Cr | −21.2% | ₹1.42 |
| Q1 FY25 | ₹57 Cr | −19.7% | ₹0 Cr | −79.3% | ₹0.43 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹2,550 Cr | ₹357 Cr |
| FY24 | ₹1,929 Cr | ₹196 Cr |
| FY23 | ₹2,188 Cr | ₹353 Cr |
| FY22 | ₹1,551 Cr | ₹253 Cr |
| FY21 | ₹829 Cr | ₹101 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 68.83%
- Foreign institutions: 1.03%
- Domestic institutions: 5.56%
- Non-institutions: 24.55%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [West Coast Paper Mills](https://app.pivotnow.in/stock/WSTCSTPAPR) | ₹828.25 | ₹5,471 Cr | 36.3 | — |
| [Prism Johnson](https://app.pivotnow.in/stock/PRSMJOHNSN) | ₹99.04 | ₹4,985 Cr | 68.3 | — |
| [UFLEX](https://app.pivotnow.in/stock/UFLEX) | ₹589.00 | ₹4,253 Cr | 13.4 | — |
| [Kaveri Seed Company](https://app.pivotnow.in/stock/KSCL) | ₹732.05 | ₹3,766 Cr | 12.9 | — |
| [Greenply Industries](https://app.pivotnow.in/stock/GREENPLY) | ₹289.30 | ₹3,613 Cr | 40.3 | — |
| [Mayur Uniquoters](https://app.pivotnow.in/stock/MAYURUNIQ) | ₹731.30 | ₹3,178 Cr | 16.6 | — |

## Questions and answers

### What is the share price of Epigral today?

Epigral (NSE: EPIGRAL) last closed at ₹949.40 on 22 Oct 2026. Its 52-week high is ₹1,729.90 and its 52-week low is ₹807.00.

### What is the market cap of Epigral?

Epigral's market capitalisation is ₹4,096 Cr (₹4,096 Cr) at the 22 Oct 2026 close, ranking 861st among the NSE companies Pivot tracks.

### What is the P/E ratio of Epigral?

Epigral trades at a trailing P/E of 12.3. The median P/E of the 6 closest Cement & Materials peers by market cap is 36.3.

### What is the ROE and ROCE of Epigral?

Return on equity was 14.9% in FY26 and return on capital employed was 14.8% in FY26 (consolidated figures).

### Is Epigral a debt-free company?

No. Epigral's debt-to-equity ratio was 0.25 in FY26, with total debt of ₹334 Cr.

### What were Epigral's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Epigral reported revenue of ₹146 Cr, +20.3% year on year, and net profit of ₹2 Cr, +71.0% year on year.

### How has Epigral stock performed over the last year?

Epigral's share price has fallen 43.6% over the past year, −16.5% over three months and −14.5% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Epigral?

As of 30 Jun 2026: promoters 68.83%, foreign institutions 1.03%, domestic institutions 5.56%, non-institutions 24.55%.

### Who are Epigral's competitors?

The listed Cement & Materials companies closest to Epigral by market cap are West Coast Paper Mills, Prism Johnson, UFLEX, Kaveri Seed Company, Greenply Industries and Mayur Uniquoters.

### Is Epigral a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Epigral's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on EPIGRAL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.